SlideShare a Scribd company logo
1 of 22
Presented By-
Md. Hafizur Rahman
General Manager
& Head of R&D
The IPI Ltd.
10/27/2022 1
10/27/2022 2
10/27/2022 3
10/27/2022 4
►Non-compartmental analysis (NCA) is a simple and quick method
for evaluating the exposure of a drug.
► It allows you to evaluate things like linearity and in vivo exposure.
► Noncompartmental analysis (NCA) provides the most elementary
pharmacokinetic information for a drug (i.e., peak concentration
and elimination half-life).
► NCAs are essential for characterizing new drug products and can
help guide development at each stage.
► It assumes that elimination follows first order
10/27/2022 5
10/27/2022 6
10/27/2022 7
NCAs often prove faster and more cost-efficient to conduct,
especially when compared to more complex compartmental
analyses (e.g., compartmental models that are applied to
population PK analyses and that rely upon sparse/few
sampling techniques)
10/27/2022 8
10/27/2022 9
10/27/2022 10
10/27/2022 11
 The MRT is calculated by summing the total time in the body and
dividing by the number of molecules, which is turns out to be 85.6
minutes. Thus MRT represents the average time a molecule stays in
the body. Equations for the mean residence time (MRT) of drug in
the body and related functions are derived for drugs which are
intravenously administered into a one- or two-compartment system
with Michaelis-Menten elimination.
10/27/2022 12
MDT is the arithmetic mean value of any release profiles (Podczeck, 1993) and is
used to describe the drug release rate, to describe the hindering ability of the
used polymer (Asaduzzaman et al., 2011) , and to compare different release
profiles statistically (Podczeck, 1993). The mean disintegration time (MDGT; mean
time required for disintegration of tablets) and mean dissolution time
(MDST; mean time required for drug dissolution) of water-soluble drugs from solid
dosage forms were determined by moment analysis using microcalorimetric
curves.
10/27/2022 13
10/27/2022 14
Time, or better said Mean Arrival Time, corresponds to the
time on average that drug molecules spend prior
absorption, or in other words, the residence time of those
molecules 'outside' the absorption. 'site'.
For noninstantaneous input into a kinetic space, such as
oral absorption, the MRT estimated from extravascular
data includes a contribution of the mean transit time for
input, known as mean absorption time (MAT, or mean
arrival time, or mean input time).
10/27/2022 15
10/27/2022 16
 The AUMC (area under the first moment curve) is the area
under the concentration times versus time curve. The first
moment curve is prepared when concentration x time is
plotted versus time.
10/27/2022 17
 The first moment curve is prepared when concentration x
time is plotted versus time. AUMC can be mathematically
expressed as: (6.6) Knowledge about AUC and AUMC allows
further calculation and analysis of drug characteristics.
10/27/2022 18
 Physiologically based pharmacokinetic (PBPK) modeling is a
computational process that simulates the absorption,
distribution, metabolism, and excretion of a substance in the
body of an organism based on the interrelationships among
key physiological, biochemical, and physicochemical factors
using mathematical equations ...
 Pharmacokinetic (PK) models are mathematical tools that allow
simulating drug concentration levels in the blood prior to real
administration. These models can have countless applications
in new drug development and clinical activities.
10/27/2022 19
10/27/2022 20
 During the discovery phase, PK/PD models can be used to
identify and select the best drug candidates, which helps
characterize the mechanism of action and disease behavior of
a given drug, to predict clinical response in humans, and to
facilitate a better understanding about the potential clinical
relevance of ...
10/27/2022 21
10/27/2022 22

More Related Content

What's hot

Types of equivalent and measurement of bioavailability
Types of equivalent and measurement of bioavailabilityTypes of equivalent and measurement of bioavailability
Types of equivalent and measurement of bioavailability
Sonam Gandhi
 
A seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationA seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administration
Malla Reddy College of Pharmacy
 

What's hot (20)

Multicompartment model IV Bolus
Multicompartment model IV BolusMulticompartment model IV Bolus
Multicompartment model IV Bolus
 
Bioequivalence studies
Bioequivalence studiesBioequivalence studies
Bioequivalence studies
 
Types of equivalent and measurement of bioavailability
Types of equivalent and measurement of bioavailabilityTypes of equivalent and measurement of bioavailability
Types of equivalent and measurement of bioavailability
 
Rate limiting steps in drug absorption [autosaved]
Rate limiting steps in drug absorption [autosaved]Rate limiting steps in drug absorption [autosaved]
Rate limiting steps in drug absorption [autosaved]
 
In-Vivo In-Vitro Correlation
In-Vivo In-Vitro CorrelationIn-Vivo In-Vitro Correlation
In-Vivo In-Vitro Correlation
 
Multiple Dosage regimen
Multiple Dosage regimenMultiple Dosage regimen
Multiple Dosage regimen
 
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
 
A seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationA seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administration
 
Non compartment model
Non compartment modelNon compartment model
Non compartment model
 
Invitro invivo insitu method
Invitro invivo insitu methodInvitro invivo insitu method
Invitro invivo insitu method
 
Non compartmental modelling
Non compartmental modellingNon compartmental modelling
Non compartmental modelling
 
Pharmacokinetic models
Pharmacokinetic  modelsPharmacokinetic  models
Pharmacokinetic models
 
Validation and validation of master plan in modern pharmaceutics.
Validation and validation of master plan in  modern pharmaceutics.Validation and validation of master plan in  modern pharmaceutics.
Validation and validation of master plan in modern pharmaceutics.
 
Computational modeling in drug disposition
Computational modeling in drug dispositionComputational modeling in drug disposition
Computational modeling in drug disposition
 
Bioavilability and Bioequivalence study designs
Bioavilability and Bioequivalence study designsBioavilability and Bioequivalence study designs
Bioavilability and Bioequivalence study designs
 
Drug Dissolution
Drug DissolutionDrug Dissolution
Drug Dissolution
 
Properties of GI tract, pH partition hypothesis
Properties of GI tract, pH partition hypothesis Properties of GI tract, pH partition hypothesis
Properties of GI tract, pH partition hypothesis
 
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
 
Role of computer in clinical development
Role of computer in clinical developmentRole of computer in clinical development
Role of computer in clinical development
 
Non linear pharmacokinetics
Non linear pharmacokineticsNon linear pharmacokinetics
Non linear pharmacokinetics
 

Similar to Non compartmental analysis.pptx

Classification of physiological signals for wheel loader operators using Mult...
Classification of physiological signals for wheel loader operators using Mult...Classification of physiological signals for wheel loader operators using Mult...
Classification of physiological signals for wheel loader operators using Mult...
Reno Filla
 
450595389ITLS5200INDIVIDUALASSIGNMENTS22015
450595389ITLS5200INDIVIDUALASSIGNMENTS22015450595389ITLS5200INDIVIDUALASSIGNMENTS22015
450595389ITLS5200INDIVIDUALASSIGNMENTS22015
Leonard Ong
 
Paper 3189
Paper 3189Paper 3189
Paper 3189
euroFOT
 
Population Pharmacokinetic Modelling of an investigational prodrug. Crunenber...
Population Pharmacokinetic Modelling of an investigational prodrug. Crunenber...Population Pharmacokinetic Modelling of an investigational prodrug. Crunenber...
Population Pharmacokinetic Modelling of an investigational prodrug. Crunenber...
robirish51
 
ICAF 2007 - On the Selection of Test Factors for the Determination of Safe Life
ICAF 2007 - On the Selection of Test Factors for the Determination of Safe LifeICAF 2007 - On the Selection of Test Factors for the Determination of Safe Life
ICAF 2007 - On the Selection of Test Factors for the Determination of Safe Life
Guy Habermann (MBA BSc BEng Hons 1)
 
Survey on deep learning applied to predictive maintenance
Survey on deep learning applied to predictive maintenance Survey on deep learning applied to predictive maintenance
Survey on deep learning applied to predictive maintenance
IJECEIAES
 

Similar to Non compartmental analysis.pptx (20)

Crimson Publishers- Create the Individualized Digital Twin for Noninvasive Pr...
Crimson Publishers- Create the Individualized Digital Twin for Noninvasive Pr...Crimson Publishers- Create the Individualized Digital Twin for Noninvasive Pr...
Crimson Publishers- Create the Individualized Digital Twin for Noninvasive Pr...
 
Classification of physiological signals for wheel loader operators using Mult...
Classification of physiological signals for wheel loader operators using Mult...Classification of physiological signals for wheel loader operators using Mult...
Classification of physiological signals for wheel loader operators using Mult...
 
450595389ITLS5200INDIVIDUALASSIGNMENTS22015
450595389ITLS5200INDIVIDUALASSIGNMENTS22015450595389ITLS5200INDIVIDUALASSIGNMENTS22015
450595389ITLS5200INDIVIDUALASSIGNMENTS22015
 
Linear Model Predictive Controller for Closed-Loop Control of Intravenous Ane...
Linear Model Predictive Controller for Closed-Loop Control of Intravenous Ane...Linear Model Predictive Controller for Closed-Loop Control of Intravenous Ane...
Linear Model Predictive Controller for Closed-Loop Control of Intravenous Ane...
 
In vitro in vivo correlation by Dr. Neeraj Mishra, ISFCP, Moga, Punjab
In vitro in vivo correlation by Dr. Neeraj Mishra, ISFCP, Moga, PunjabIn vitro in vivo correlation by Dr. Neeraj Mishra, ISFCP, Moga, Punjab
In vitro in vivo correlation by Dr. Neeraj Mishra, ISFCP, Moga, Punjab
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
Paper 3189
Paper 3189Paper 3189
Paper 3189
 
Population Pharmacokinetic Modelling of an investigational prodrug. Crunenber...
Population Pharmacokinetic Modelling of an investigational prodrug. Crunenber...Population Pharmacokinetic Modelling of an investigational prodrug. Crunenber...
Population Pharmacokinetic Modelling of an investigational prodrug. Crunenber...
 
BEARINGS PROGNOSTIC USING MIXTURE OF GAUSSIANS HIDDEN MARKOV MODEL AND SUPPOR...
BEARINGS PROGNOSTIC USING MIXTURE OF GAUSSIANS HIDDEN MARKOV MODEL AND SUPPOR...BEARINGS PROGNOSTIC USING MIXTURE OF GAUSSIANS HIDDEN MARKOV MODEL AND SUPPOR...
BEARINGS PROGNOSTIC USING MIXTURE OF GAUSSIANS HIDDEN MARKOV MODEL AND SUPPOR...
 
BEARINGS PROGNOSTIC USING MIXTURE OF GAUSSIANS HIDDEN MARKOV MODEL AND SUPPOR...
BEARINGS PROGNOSTIC USING MIXTURE OF GAUSSIANS HIDDEN MARKOV MODEL AND SUPPOR...BEARINGS PROGNOSTIC USING MIXTURE OF GAUSSIANS HIDDEN MARKOV MODEL AND SUPPOR...
BEARINGS PROGNOSTIC USING MIXTURE OF GAUSSIANS HIDDEN MARKOV MODEL AND SUPPOR...
 
Six sigma dmaic methodology as a support tool for health technology assessmen...
Six sigma dmaic methodology as a support tool for health technology assessmen...Six sigma dmaic methodology as a support tool for health technology assessmen...
Six sigma dmaic methodology as a support tool for health technology assessmen...
 
Computational Modeling of Drug Disposition
Computational Modeling of Drug Disposition  Computational Modeling of Drug Disposition
Computational Modeling of Drug Disposition
 
ICAF 2007 - On the Selection of Test Factors for the Determination of Safe Life
ICAF 2007 - On the Selection of Test Factors for the Determination of Safe LifeICAF 2007 - On the Selection of Test Factors for the Determination of Safe Life
ICAF 2007 - On the Selection of Test Factors for the Determination of Safe Life
 
Ambulance Diversions Reducing and Dispatching Theory for Rescue Operations
Ambulance Diversions Reducing and Dispatching Theory for Rescue OperationsAmbulance Diversions Reducing and Dispatching Theory for Rescue Operations
Ambulance Diversions Reducing and Dispatching Theory for Rescue Operations
 
Survey on deep learning applied to predictive maintenance
Survey on deep learning applied to predictive maintenance Survey on deep learning applied to predictive maintenance
Survey on deep learning applied to predictive maintenance
 
Markov chain for the recommendation of
Markov chain for the recommendation ofMarkov chain for the recommendation of
Markov chain for the recommendation of
 
MARKOV CHAIN FOR THE RECOMMENDATION OF MATERIALIZED VIEWS IN REAL-TIME DATA W...
MARKOV CHAIN FOR THE RECOMMENDATION OF MATERIALIZED VIEWS IN REAL-TIME DATA W...MARKOV CHAIN FOR THE RECOMMENDATION OF MATERIALIZED VIEWS IN REAL-TIME DATA W...
MARKOV CHAIN FOR THE RECOMMENDATION OF MATERIALIZED VIEWS IN REAL-TIME DATA W...
 
Markov Chain for the Recommendation of Materialized Views in Real-Time Data W...
Markov Chain for the Recommendation of Materialized Views in Real-Time Data W...Markov Chain for the Recommendation of Materialized Views in Real-Time Data W...
Markov Chain for the Recommendation of Materialized Views in Real-Time Data W...
 
Real-time and Non-Invasive Detection of Haemoglobin level using CNN
Real-time and Non-Invasive Detection of Haemoglobin level using CNNReal-time and Non-Invasive Detection of Haemoglobin level using CNN
Real-time and Non-Invasive Detection of Haemoglobin level using CNN
 
1.pharmacokinetics
1.pharmacokinetics1.pharmacokinetics
1.pharmacokinetics
 

More from HafizurRahman130404

Presentation_Pharma_Training_LYCOAT_READILYCOAT_XP_06_2012.ppt
Presentation_Pharma_Training_LYCOAT_READILYCOAT_XP_06_2012.pptPresentation_Pharma_Training_LYCOAT_READILYCOAT_XP_06_2012.ppt
Presentation_Pharma_Training_LYCOAT_READILYCOAT_XP_06_2012.ppt
HafizurRahman130404
 
QbD+IR+Final+April+2012-508-Final2.pdf
QbD+IR+Final+April+2012-508-Final2.pdfQbD+IR+Final+April+2012-508-Final2.pdf
QbD+IR+Final+April+2012-508-Final2.pdf
HafizurRahman130404
 
Chanllenge and Impact after LDC Gradution-11-Oct,21 -Final.pptx
Chanllenge and Impact after LDC Gradution-11-Oct,21 -Final.pptxChanllenge and Impact after LDC Gradution-11-Oct,21 -Final.pptx
Chanllenge and Impact after LDC Gradution-11-Oct,21 -Final.pptx
HafizurRahman130404
 
ard-food-safety-training-good-manufacturing-practices-presentation.ppt
ard-food-safety-training-good-manufacturing-practices-presentation.pptard-food-safety-training-good-manufacturing-practices-presentation.ppt
ard-food-safety-training-good-manufacturing-practices-presentation.ppt
HafizurRahman130404
 

More from HafizurRahman130404 (19)

Presentation on Good Laboratory Practice pptx
Presentation on Good Laboratory Practice pptxPresentation on Good Laboratory Practice pptx
Presentation on Good Laboratory Practice pptx
 
Volume 6 : Excipients of Sterile Products _1.pdf
Volume 6 : Excipients of Sterile Products _1.pdfVolume 6 : Excipients of Sterile Products _1.pdf
Volume 6 : Excipients of Sterile Products _1.pdf
 
Volume 4 : Excipients of Semisolid Products _1.pdf
Volume 4 : Excipients of Semisolid Products _1.pdfVolume 4 : Excipients of Semisolid Products _1.pdf
Volume 4 : Excipients of Semisolid Products _1.pdf
 
Volume 3 Liquid Products_Excipients1.pdf
Volume 3  Liquid Products_Excipients1.pdfVolume 3  Liquid Products_Excipients1.pdf
Volume 3 Liquid Products_Excipients1.pdf
 
Volume 2 Uncompressed Solid Products _1.pdf
Volume 2 Uncompressed Solid Products _1.pdfVolume 2 Uncompressed Solid Products _1.pdf
Volume 2 Uncompressed Solid Products _1.pdf
 
Volume 1 Compressed Solid Products _1.pdf
Volume  1 Compressed Solid Products _1.pdfVolume  1 Compressed Solid Products _1.pdf
Volume 1 Compressed Solid Products _1.pdf
 
Volume 5 Over-the-Counter Products _1.pdf
Volume 5 Over-the-Counter Products _1.pdfVolume 5 Over-the-Counter Products _1.pdf
Volume 5 Over-the-Counter Products _1.pdf
 
biopharm-international-september-2022.pdf
biopharm-international-september-2022.pdfbiopharm-international-september-2022.pdf
biopharm-international-september-2022.pdf
 
Presentation_Pharma_Training_LYCOAT_READILYCOAT_XP_06_2012.ppt
Presentation_Pharma_Training_LYCOAT_READILYCOAT_XP_06_2012.pptPresentation_Pharma_Training_LYCOAT_READILYCOAT_XP_06_2012.ppt
Presentation_Pharma_Training_LYCOAT_READILYCOAT_XP_06_2012.ppt
 
Packaging.ppt
Packaging.pptPackaging.ppt
Packaging.ppt
 
Packaging.ppt
Packaging.pptPackaging.ppt
Packaging.ppt
 
Presentation22.ppt
Presentation22.pptPresentation22.ppt
Presentation22.ppt
 
Presentation on Weighing & Dispensing.ppt
Presentation on Weighing & Dispensing.pptPresentation on Weighing & Dispensing.ppt
Presentation on Weighing & Dispensing.ppt
 
WHO- Self Inspection & Quality Audit_2012.ppt
WHO- Self Inspection & Quality Audit_2012.pptWHO- Self Inspection & Quality Audit_2012.ppt
WHO- Self Inspection & Quality Audit_2012.ppt
 
QbD+IR+Final+April+2012-508-Final2.pdf
QbD+IR+Final+April+2012-508-Final2.pdfQbD+IR+Final+April+2012-508-Final2.pdf
QbD+IR+Final+April+2012-508-Final2.pdf
 
Chanllenge and Impact after LDC Gradution-11-Oct,21 -Final.pptx
Chanllenge and Impact after LDC Gradution-11-Oct,21 -Final.pptxChanllenge and Impact after LDC Gradution-11-Oct,21 -Final.pptx
Chanllenge and Impact after LDC Gradution-11-Oct,21 -Final.pptx
 
ard-food-safety-training-good-manufacturing-practices-presentation.ppt
ard-food-safety-training-good-manufacturing-practices-presentation.pptard-food-safety-training-good-manufacturing-practices-presentation.ppt
ard-food-safety-training-good-manufacturing-practices-presentation.ppt
 
Basic_Diagnostics_Method_in_Medicine.ppt
Basic_Diagnostics_Method_in_Medicine.pptBasic_Diagnostics_Method_in_Medicine.ppt
Basic_Diagnostics_Method_in_Medicine.ppt
 
Intravenous Infusion.pptx
Intravenous Infusion.pptxIntravenous Infusion.pptx
Intravenous Infusion.pptx
 

Recently uploaded

The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 
Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
AnaAcapella
 

Recently uploaded (20)

On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 
Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 

Non compartmental analysis.pptx

  • 1. Presented By- Md. Hafizur Rahman General Manager & Head of R&D The IPI Ltd. 10/27/2022 1
  • 5. ►Non-compartmental analysis (NCA) is a simple and quick method for evaluating the exposure of a drug. ► It allows you to evaluate things like linearity and in vivo exposure. ► Noncompartmental analysis (NCA) provides the most elementary pharmacokinetic information for a drug (i.e., peak concentration and elimination half-life). ► NCAs are essential for characterizing new drug products and can help guide development at each stage. ► It assumes that elimination follows first order 10/27/2022 5
  • 8. NCAs often prove faster and more cost-efficient to conduct, especially when compared to more complex compartmental analyses (e.g., compartmental models that are applied to population PK analyses and that rely upon sparse/few sampling techniques) 10/27/2022 8
  • 12.  The MRT is calculated by summing the total time in the body and dividing by the number of molecules, which is turns out to be 85.6 minutes. Thus MRT represents the average time a molecule stays in the body. Equations for the mean residence time (MRT) of drug in the body and related functions are derived for drugs which are intravenously administered into a one- or two-compartment system with Michaelis-Menten elimination. 10/27/2022 12
  • 13. MDT is the arithmetic mean value of any release profiles (Podczeck, 1993) and is used to describe the drug release rate, to describe the hindering ability of the used polymer (Asaduzzaman et al., 2011) , and to compare different release profiles statistically (Podczeck, 1993). The mean disintegration time (MDGT; mean time required for disintegration of tablets) and mean dissolution time (MDST; mean time required for drug dissolution) of water-soluble drugs from solid dosage forms were determined by moment analysis using microcalorimetric curves. 10/27/2022 13
  • 15. Time, or better said Mean Arrival Time, corresponds to the time on average that drug molecules spend prior absorption, or in other words, the residence time of those molecules 'outside' the absorption. 'site'. For noninstantaneous input into a kinetic space, such as oral absorption, the MRT estimated from extravascular data includes a contribution of the mean transit time for input, known as mean absorption time (MAT, or mean arrival time, or mean input time). 10/27/2022 15
  • 17.  The AUMC (area under the first moment curve) is the area under the concentration times versus time curve. The first moment curve is prepared when concentration x time is plotted versus time. 10/27/2022 17
  • 18.  The first moment curve is prepared when concentration x time is plotted versus time. AUMC can be mathematically expressed as: (6.6) Knowledge about AUC and AUMC allows further calculation and analysis of drug characteristics. 10/27/2022 18
  • 19.  Physiologically based pharmacokinetic (PBPK) modeling is a computational process that simulates the absorption, distribution, metabolism, and excretion of a substance in the body of an organism based on the interrelationships among key physiological, biochemical, and physicochemical factors using mathematical equations ...  Pharmacokinetic (PK) models are mathematical tools that allow simulating drug concentration levels in the blood prior to real administration. These models can have countless applications in new drug development and clinical activities. 10/27/2022 19
  • 21.  During the discovery phase, PK/PD models can be used to identify and select the best drug candidates, which helps characterize the mechanism of action and disease behavior of a given drug, to predict clinical response in humans, and to facilitate a better understanding about the potential clinical relevance of ... 10/27/2022 21